139th National Cancer Advisory Board
WEDNESDAY, SEPTEMBER 6, 2006
CALL TO ORDER, OPENING REMARKS, AND APPROVAL OF MINUTES— DR. CAROLYN D. RUNOWICZ
Dr. Carolyn D. Runowicz, Director, The Carole and Ray Neag Comprehensive Cancer Center, Farmington, CT, called to order the 139th NCAB meeting. She welcomed members of the Board, the President’s Cancer Panel, ex officio members of the Board, staff, and guests. New members to the Board were introduced. They are: Dr. Anthony Atala, Director, Wake Forest Institute for Regenerative Medicine, and Professor and Chairman, Department of Urology, Wake Forest University School of Medicine; Dr. Bruce Chabner, Clinical Director, Massachusetts General Hospital Cancer Center; Dr. Donald Coffey, The Catherine Iola and J. Smith Michael Distinguished Professor of Urology, Johns Hopkins University School of Medicine; Dr. Lloyd Everson, Vice Chairman and Member of the Board of Directors, US Oncology Incorporated; Dr. Judah Folkman, Director, Vascular Biology Program, Children’s Hospital of Boston, and Julia Dyckman Andrus Professor of Pediatric Surgery and Professor of Cell Biology, Harvard Medical School; Mr. Robert Ingram, Vice Chairman, Pharmaceuticals, GlaxoSmithKline; and Dr. Karen Meneses, Professor, School of Nursing, and Beat M. and Jill L. Kahli Endowed Chair in Oncology, University of Central Florida. Dr. Runowicz called attention to a recent Wall Street Journal article entitled “Patients with Rare Diseases Work to Jump Start Research,” which chronicled the work of NCAB member Ms. Kathryn Giusti, CEO and Founder, Multiple Myeloma Research Foundation, Inc. Members of the public were welcomed and invited to submit to Dr. Paulette S. Gray, Director, Division of Extramural Activities (DEA), in writing and within 10 days, any comments regarding items discussed during the meeting. Dr. Runowicz then reviewed the confidentiality and conflict-of-interest practices required of Board members in their deliberations.
Motion. A motion was made to approve the minutes of the June 14, 2006, NCAB meeting. The motion was seconded, and the Board unanimously approved the minutes.
FUTURE BOARD MEETING DATES—DR. CAROLYN D. RUNOWICZ
Dr. Runowicz called Board members’ attention to future meeting dates, which have been confirmed through 2008.
NCI DIRECTOR’S REPORT—DR. JOHN NIEDERHUBER
Dr. John Niederhuber announced the official appointment of Dr. Runowicz as Chairperson of the NCAB, and he extended congratulations. He welcomed the new NCAB members who had been introduced earlier by Dr. Runowicz and expressed satisfaction that the group of knowledgeable and dedicated individuals nominated by the NCI had been selected to join the other sitting members in providing advice and leadership to the NCI.
Honors and Appointments. Dr. Niederhuber announced the most recent honors accorded NCI staff and appointments within the NCI. Drs. John T. Schiller and Douglas Lowy, Laboratory of Cellular Oncology, Center for Cancer Research (CCR), received the Department of Health and Human Services (DHHS) Honor Award for research on the human papillomavirus. Dr. Norman Coleman, Radiation Oncology Branch, CCR, and Dr. Lee J. Helman, Pediatric Oncology Branch, CCR, received the DHHS Honor Award for contributions to NCI’s Katrina Relief Team. Dr. Dan Gallahan was appointed Deputy Director, Division of Cancer Biology, and Dr. Lenora Johnson was appointed Acting Director, Office of Liaison Activities.